Key Metrics for HealthTech Startups at Series A Stage: Investor Benchmarks
These 5 metrics are what institutional investors evaluate when screening HealthTech startups at the Series A stage. Each metric is accompanied by benchmark ranges sourced from our database of 3+ comparable company analyses.
Metrics Expected at Series A: $500K–$3M ARR, NRR >100%, Gross Margin >65%, CAC Payback <18 months
01. Clinical Outcome Improvement
The most defensible moat in healthtech
02. Payor Contract Rate
Without payor coverage, patient adoption is limited to self-pay
03. Provider Adoption Rate
Provider behavior change is notoriously difficult
04. Patient Engagement Rate
Low engagement undermines outcome claims
05. Average Selling Price (ASP)
Enterprise health system deals have 9–18 month sales cycles
How DDR Benchmarks These Metrics
When you upload a HealthTech startup pitch deck, DDR automatically:
- Extracts all HealthTech metrics from every slide of the pitch deck
- Benchmarks each metric against 3 comparable HealthTech companies
- Flags metrics outside healthy ranges as red flags with severity weighting
- Provides an overall verdict (INVEST / DIG DEEPER / PASS) with score 1–10
- Generates expected return scenarios based on HealthTech exit data
HealthTech Due Diligence — All Guides
Screen Any HealthTech Startup in 5 Minutes
Upload a pitch deck PDF and DDR automatically runs this full due diligence framework — 13 OSINT sources, founder verification, all sector-specific red flags, comparable company analysis, and INVEST/PASS verdict.
GET YOUR FREE SCAN →